頸動(dòng)脈產(chǎn)品介紹 - 支架-in service

CarotidWALLSTENTTM

頸動(dòng)脈支架?支架自膨支架Elgiloy?

金屬絲編制管狀網(wǎng)眼結(jié)構(gòu)2支架輸送系統(tǒng)Monorail?導(dǎo)管設(shè)計(jì)，0.014“導(dǎo)絲輸送系統(tǒng)；5F(6&8mm)和6F(10mm)低外廓，高柔順性；

CarotidWALLSTENTTM

頸動(dòng)脈支架閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydiseaseCarotidWALLSTENTTM

頸動(dòng)脈支架閉環(huán)單元結(jié)構(gòu)，獨(dú)特的支架設(shè)計(jì)提供最大化的斑塊覆蓋高度的柔順性便于使用的輸送系統(tǒng)*FreeCellArea:Measurestheaveragearea(mm2)withintheperimeterofconnectingstruts.Smallernumber=smallerfreecellarea.CarotidWALLSTENTTM

頸動(dòng)脈支架支架設(shè)計(jì)-閉環(huán)

Vs.開環(huán)閉環(huán)支架設(shè)計(jì)CarotidWALLSTENT?EndoprosthesisXact?CarotidStent開環(huán)支架設(shè)計(jì)Precise?PRORx

NitinolStentSystemRXAcculink?CarotidStentCarotidWALLSTENTEndoprosthesisPrecisePRORxNitinolStentSystemRXAcculinkCarotidStentImagestakenbyandonfileatBSC.IllustrationsbyBSC.PreciseProisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.閉環(huán)支架設(shè)計(jì)CWS與其他頸動(dòng)脈支架相比，具有最小的支架網(wǎng)孔面積**CarotidWALLSTENT?

閉環(huán)設(shè)計(jì)提供最大化的斑塊覆蓋以及光滑平整的管腔

**TestingperformedonCarotidWALLSTENTEndoprosthesis8mmx21mm,PreciseProRX8mmx40mm,RXACCULINK7-10mmx40mm,Xact7-9mmx40mm.Benchtestresultsmaynotnecessarilybeindicativeofclinicalperformance.Testresultsshownareformodelsdeemedmosttypicallyselectedforplacementincommoncarotidarterywithareferencediameterof<8mm.Othermodelswerealsotestedandyieldedsimilarresults.N=3.Dataonfile.PreciseProisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.*FreeCellArea:測(cè)量支架連接小桿周長(zhǎng)間的平均面積數(shù)值越小=支架網(wǎng)孔面積越小PhotographstakenbyBostonScientificCorporation閉環(huán)支架設(shè)計(jì)CarotidWALLSTENT?

閉環(huán)設(shè)計(jì)提供最大化的斑塊覆蓋以及光滑平整的管腔

DoesCarotidStentDesignInfluenceOutcomes?

R.M.Bersin,CatheterizationandCardiovascularInterventions2008;72:863–866目前為止，已經(jīng)完成3項(xiàng)有關(guān)頸動(dòng)脈支架設(shè)計(jì)與臨床結(jié)果的回顧性、非隨機(jī)研究。DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.Aretrospectiveanalysisof30dayoutcomesofacarotidarterystentingmulticenterdatabaseconsistingof3179consecutivepatientsSPACE,aretrospective,randomizedtrialofcarotidarterystentingversusendarterectomyinstandardsurgicalriskpatientswithsymptomaticcarotidarterystenosesSchillingerM,GschwendtnerM,ReimersB,etal.Doescarotidstentcelldesignmatter?Aretrospective,nonrandomizedreviewofacarotidarterystentingmulticenterdatabaseconsistingof1,684consecutivepatientsDoesCarotidStentDesignInfluenceOutcomes?

Bersin.CatheterizationandCardiovascularInterventions2008;72:863–866..DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.目的:明確頸動(dòng)脈支架設(shè)計(jì)，尤其是支架網(wǎng)孔面積，對(duì)于頸動(dòng)脈支架術(shù)后30天卒中、死亡或TIA的影響。

30天結(jié)果的回顧性分析TIA，死亡,大和小卒中(非心肌梗死)共3179接受頸動(dòng)脈支架手術(shù)的患者4個(gè)中心Bosiers,Deloose-BelgiumPeeters,Verbis-BelgiumSetacci,Donatoetal.-ItalyCremonesi,Castriota-ItalyDoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.DoesFreeCellAreaInfluencetheOutcomein

CarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.

閉環(huán)支架定義為支架網(wǎng)孔面積<5.0mm2例如CarotidWALLSTENT?EndoprosthesisXACT?Carotid

Stent開環(huán)支架定義為支架網(wǎng)孔面積>5.0mm2例如Precise?Rx

NitinolStentSystemRXAcculink?CarotidStentDoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.PreciseisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.第30天事件：閉環(huán)

vs.開環(huán)支架設(shè)計(jì)

TIA,死亡,大和小卒中DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.對(duì)于癥狀性患者，術(shù)后第30天的主要事件發(fā)生率差異顯著開環(huán)支架設(shè)計(jì)(7.0%)VS

閉環(huán)支架設(shè)計(jì)(2.2%)(p<0.0001)DoesFreeCellAreaInfluencetheOutcomein

CarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.

N=3179P=0.005N=1317P<0.0001N=1862P=1.0DoesFreeCellAreaInfluencetheOutcomein

CarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.

術(shù)后=(TIA,卒中,死亡)直到術(shù)后30天發(fā)生閉環(huán)

vs.開環(huán)支架設(shè)計(jì)DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.對(duì)于癥狀性患者，手術(shù)30天以后的主要事件發(fā)生率差異顯著開環(huán)支架設(shè)計(jì)(6.3%)VS閉環(huán)支架設(shè)計(jì)(1.3%)(p<0.0001)N=3179P<0.0001N=1317P<0.0001N=1862P=1.0患者評(píng)估由獨(dú)立神經(jīng)病學(xué)醫(yī)師進(jìn)行神經(jīng)學(xué)上的局限性回顧性的研究非隨機(jī)設(shè)計(jì)可能導(dǎo)致在選擇時(shí)會(huì)因特定病變類型有所偏向注冊(cè)數(shù)據(jù)受制于自我審計(jì)技術(shù)復(fù)雜性沒有評(píng)估，結(jié)果沒有經(jīng)過風(fēng)險(xiǎn)校正有必要進(jìn)行前瞻性的隨機(jī)研究來比較不同支架網(wǎng)孔面積以得到最終結(jié)論DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.DoesFreeCellAreaInfluencetheOutcomein

CarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.

總結(jié)四個(gè)中心的30天結(jié)果回顧性分析N=3179CASpatients對(duì)于癥狀性患者，術(shù)后第30天的主要事件發(fā)生率差異顯著，開環(huán)支架設(shè)計(jì)(7.0%)VS閉環(huán)支架設(shè)計(jì)(2.2%)(p<0.0001)對(duì)于癥狀性患者，手術(shù)30天以后的主要事件發(fā)生率差異顯著，開環(huán)支架設(shè)計(jì)(6.3%)VS閉環(huán)支架設(shè)計(jì)(1.3%)(p<0.0001)DoesFreeCellAreaInfluencetheOutcomeinCarotidArteryStenting?Bosiersetal.EurJVascEndovascSurg2007;33:135-141.DoesFreeCellAreaInfluencetheOutcomein

CarotidArteryStenting?

Bosiersetal.EurJVascEndovascSurg2007;33:135-141.

CarotidWALLSTENT?Endoprosthesis閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydisease跟蹤性極佳的SDS-支架輸送系統(tǒng)獨(dú)特的編織結(jié)構(gòu)提高支架的柔順性CarotidWALLSTENT?具有高度柔順的輸送系統(tǒng)，提供卓越的跟蹤性以通過扭曲病變TestingperformedonCarotidWALLSTENTEndoprosthesis8mmx21mm,PreciseProRX8mmx40mm,RXACCULINK7-10mmx40mm,Xact7-9mmx40mm.Benchtestresultsmaynotnecessarilybeindicativeofclinicalperformance.Testresultsshownareformodelsdeemedmosttypicallyselectedforplacementincommoncarotidarterywithareferencediameterof<8mm.Othermodelswerealsotestedandyieldedsimilarresults.N=3.Dataonfile.PreciseProisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.DeliveryForce:Benchtestthatmeasuresthemaximumforcerequiredtonavigatethroughabenchmodeloftortuosity.Smallervalues=Lessforcerequired低外廓的輸送系統(tǒng)直徑≤8mm直徑>8mmCarotidWALLSTENT?Endoprosthesis5F6FXact?CarotidStent6F6FRXAcculink?CarotidStent6F6FPrecise?PRORxNitinolStentSystem5F6F匹配的導(dǎo)引鞘*(VesselSize)*InformationexcerptedfromrespectiveDFUs.PreciseProisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.低外廓設(shè)計(jì)允許其通過5For6F血管鞘

CarotidWALLSTENT?的低外廓支架輸送系統(tǒng)使其具有卓越的跟蹤性以通過迂曲的解剖結(jié)構(gòu)便于使用Thepin-and-pulldeliverysystemisdesignedtosimplifydeliveryCarotidWALLSTENT?EndoprosthesisDeliverySystemFinalAssembly.ImagepropertyofBostonScientificCorporation.Notnecessarilytoscale.閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydiseaseCarotidWALLSTENTTM

頸動(dòng)脈支架出色的顯影性在對(duì)比測(cè)試中，與其他頸動(dòng)脈支架相比，CarotidWALLSTENT是顯影性最好的支架CarotidWALLSTENT?的設(shè)計(jì)使支架具有高度可視性，便于支架的精確釋放TestingperformedonCarotidWALLSTENTEndoprosthesis8mmx21mm,PreciseProRX8mmx40mm,RXACCULINK7-10mmx40mm,Xact7-9mmx40mm.Benchtestresultsmaynotnecessarilybeindicativeofclinicalperformance.Testresultsshownareformodelsdeemedmosttypicallyselectedforplacementincommoncarotidarterywithareferencediameterof<8mm.Othermodelswerealsotestedandyieldedsimilarresults.N=3.Dataonfile.PreciseProisatrademarkofCordisCorporation,AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,andXactistrademarkofMedNova,Ltd.Xact?StentProtege?StentRXAcculink?StentPrecise?

ProNitinolStentCarotidWALLSTENTRadiopacity:BenchtestthatillustratesthevisibilityofastentunderC-armunderneathsimulatedtissueImagecourtesyofDr.Hoffman

IllustratestheinvivovisibilityofCarotidWALLSTENTandtheRxAcculinkCarotidstent.Maynotbeindicativeofclinicalperformance..

AcculinkisatrademarkofAbbottCardiovascularSystems,Inc,CarotidWALLSTENT?EndoprosthesisRXAcculink?CarotidStent出色的顯影性出色的顯影性DistalInnerROMarkerOuterDistalROMarkerAllPhotographstakenbyBostonScientificCorporation內(nèi)桿及外鞘上的可回收標(biāo)記點(diǎn)均不透射線，幫助支架的定位閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydiseaseCarotidWALLSTENTTM

頸動(dòng)脈支架獨(dú)特的可回收能力**Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.CarotidWALLSTENT?的獨(dú)特設(shè)計(jì)使其可以重新回收再釋放，幫助支架的精確釋放獨(dú)特的導(dǎo)管結(jié)構(gòu)和支架設(shè)計(jì)使支架在其在釋放少于50%時(shí)都可以回收再釋放DFU中與回收相關(guān)的注意事項(xiàng)*:只有在必要時(shí)才進(jìn)行回收當(dāng)支架已解除斑塊時(shí)，應(yīng)該嚴(yán)格避免回收回收次數(shù)不能超過2次不可回收標(biāo)記點(diǎn)CarotidWALLSTENT?EndoprosthesisDeliverySystemFinalAssembly.ImagepropertyofBostonScientificCorporation.Notnecessarilytoscale.*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.獨(dú)特的可回收能力*顯示支架回縮的“不可回收點(diǎn)”只要外鞘的回撤未超過不可回收標(biāo)記點(diǎn)，醫(yī)生都可以對(duì)支架進(jìn)行回收重新釋放（不超過2次，未接觸斑塊）閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydiseaseCarotidWALLSTENTTM

頸動(dòng)脈支架閉環(huán)設(shè)計(jì)跟蹤性極佳的SDS-支架輸送系統(tǒng)卓越的顯影性獨(dú)特的可回收能力*

唯一經(jīng)FDA批準(zhǔn)可用于雙側(cè)治療頸動(dòng)脈支架**臨床數(shù)據(jù)支持*Pleasenotethatreconstrainmentandrepositioningaresubjecttospecificlimitations.PleaserefertoDFUcautionsandwarningsforadditionalinformation.**TheCarotidWALLSTENTEndoprosthesisisindicatedforuseineligiblepatientswithipsilateralorbilateralcarotidarterydiseaseCarotidWALLSTENTTM

頸動(dòng)脈支架28尺寸的正確選擇CarotidWALLSTENTTM

頸動(dòng)脈支架CarotidWALLSTENT?Monorail?支架輸